TW279857B - - Google Patents

Info

Publication number
TW279857B
TW279857B TW082102087A TW82102087A TW279857B TW 279857 B TW279857 B TW 279857B TW 082102087 A TW082102087 A TW 082102087A TW 82102087 A TW82102087 A TW 82102087A TW 279857 B TW279857 B TW 279857B
Authority
TW
Taiwan
Application number
TW082102087A
Other languages
Chinese (zh)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of TW279857B publication Critical patent/TW279857B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW082102087A 1992-03-03 1993-03-20 TW279857B (enrdf_load_html_response)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929204565A GB9204565D0 (en) 1992-03-03 1992-03-03 Pharmaceuticals

Publications (1)

Publication Number Publication Date
TW279857B true TW279857B (enrdf_load_html_response) 1996-07-01

Family

ID=10711400

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082102087A TW279857B (enrdf_load_html_response) 1992-03-03 1993-03-20

Country Status (11)

Country Link
EP (1) EP0629198A1 (enrdf_load_html_response)
JP (1) JPH07504428A (enrdf_load_html_response)
KR (1) KR950700285A (enrdf_load_html_response)
AU (1) AU666357B2 (enrdf_load_html_response)
CA (1) CA2131381A1 (enrdf_load_html_response)
GB (1) GB9204565D0 (enrdf_load_html_response)
MX (1) MX9301157A (enrdf_load_html_response)
NZ (1) NZ249217A (enrdf_load_html_response)
TW (1) TW279857B (enrdf_load_html_response)
WO (1) WO1993018027A1 (enrdf_load_html_response)
ZA (1) ZA931430B (enrdf_load_html_response)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5852014A (en) * 1992-03-12 1998-12-22 Smithkline Beecham P.L.C. Condensed indole derivatives as 5HT4 -receptor antagonists
US5998409A (en) * 1992-03-12 1999-12-07 Smithkline Beecham Plc Condensed indole derivatives as 5HT4 -receptor antagonists
WO1994008965A1 (en) * 1992-10-16 1994-04-28 Smithkline Beecham Plc N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-ht4 receptor antagonists
GB9310582D0 (en) * 1993-05-22 1993-07-07 Smithkline Beecham Plc Pharmaceuticals
IT1275903B1 (it) * 1995-03-14 1997-10-24 Boehringer Ingelheim Italia Esteri e ammidi della 1,4-piperidina disostituita
IL138568A0 (en) * 1998-04-28 2001-10-31 Dainippon Pharmaceutical Co 1-[(1-substituted-4-piperidinyl) methyl] -4- piperidine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor
BRPI0414105B8 (pt) * 2003-09-03 2021-05-25 Askat Inc compostos de benzimidazolona com atividade agonista do receptor 5-ht4
EA010891B9 (ru) 2004-06-15 2012-08-30 Пфайзер Инк. Производные бензимидазолонкарбоновой кислоты
US7737163B2 (en) 2004-06-15 2010-06-15 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
AP2418A (en) * 2004-06-15 2012-06-04 Pfizer Benzimidazolone carboxylic acid derivatives.
JP2008509088A (ja) * 2004-09-02 2008-03-27 ファイザー株式会社 ベンズイミダゾロンカルボン酸誘導体
EA012615B1 (ru) * 2005-02-22 2009-10-30 Пфайзер Инк. Производные оксииндола в качестве агонистов 5-htрецептора
ES2357362T3 (es) 2005-03-15 2011-04-25 Pfizer, Inc. Derivados de bencimidazolona como ligandos del receptor cb2.
US8592427B2 (en) 2010-06-24 2013-11-26 Alkermes Pharma Ireland Limited Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2053451T3 (es) * 1986-01-07 1994-08-01 Beecham Group Plc Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles.
IT1231413B (it) * 1987-09-23 1991-12-04 Angeli Inst Spa Derivati dell'acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht

Also Published As

Publication number Publication date
AU3571893A (en) 1993-10-05
NZ249217A (en) 1996-06-25
KR950700285A (ko) 1995-01-16
WO1993018027A1 (en) 1993-09-16
CA2131381A1 (en) 1993-09-16
MX9301157A (es) 1994-07-29
AU666357B2 (en) 1996-02-08
GB9204565D0 (en) 1992-04-15
EP0629198A1 (en) 1994-12-21
JPH07504428A (ja) 1995-05-18
ZA931430B (en) 1993-10-22

Similar Documents

Publication Publication Date Title
DK0598561T3 (enrdf_load_html_response)
DK0553875T3 (enrdf_load_html_response)
TW279857B (enrdf_load_html_response)
DK0574087T3 (enrdf_load_html_response)
DK0596750T3 (enrdf_load_html_response)
DK0576346T3 (enrdf_load_html_response)
DK0554977T3 (enrdf_load_html_response)
TW225557B (enrdf_load_html_response)
DK0581129T3 (enrdf_load_html_response)
DK0564197T3 (enrdf_load_html_response)
DK0576097T3 (enrdf_load_html_response)
DK0590732T3 (enrdf_load_html_response)
AU632452B2 (enrdf_load_html_response)
TW236645B (enrdf_load_html_response)
IN185996B (enrdf_load_html_response)
AU2098792A (enrdf_load_html_response)
IN181065B (enrdf_load_html_response)
IN183090B (enrdf_load_html_response)
IN184903B (enrdf_load_html_response)
IN177380B (enrdf_load_html_response)
IN178227B (enrdf_load_html_response)
AU2527592A (enrdf_load_html_response)
AU1286992A (enrdf_load_html_response)
AU1812892A (enrdf_load_html_response)
AU1711092A (enrdf_load_html_response)